Advertisement

Drugs & Therapy Perspectives

, Volume 34, Issue 11, pp 518–521 | Cite as

Overcome the challenges of drug administration in children by developing age-appropriate formulations

  • Adis Medical Writers
Practical Issues and Updates
  • 31 Downloads

Abstract

Interest in developing age-appropriate formulations of drugs to optimize pharmacological therapy in children continues to grow. With oral formulations being the most common route of administration, several factors relating to the formulation and bitter taste of drugs can impact the acceptability of medications in children. Approaches to improve medication acceptability include the use of alternative delivery systems, taste-masking strategies and the development of new technologies for formulation preparation.

Notes

Compliance with ethical standards

Conflict of interest

The article was adapted from Pharmaceutical Medicine 2018;32(1):21-30 [1] by employees of Adis/Springer, who are responsible for the article content and declare no conflicts of interest.

Funding

The preparation of this review was not supported by any external funding.

References

  1. 1.
    Rieder M. Size and taste matters: recent progress in the development of age-appropriate medicines for children. Pharmaceut Med. 2018;32(1):21–30.Google Scholar
  2. 2.
    Baguley D, Lim E, Bevan A, et al. Prescribing for children - taste and palatability affect adherence to antibiotics: a review. Arch Dis Child. 2012;97(3):293–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Caffarel-Salvador E, Tuan-Mahmood TM, McElnay JC, et al. Potential of hydrogel-forming and dissolving microneedles for use in paediatric populations. Int J Pharm. 2015;489(1–2):158–69.PubMedCrossRefGoogle Scholar
  4. 4.
    Zajicek A, Fossler MJ, Barrett JS, et al. A report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage forms. AAPS Pharm Sci Tech. 2013;15:1072–81.Google Scholar
  5. 5.
    Klingmann V, Seitz A, Meissner T, et al. Acceptability of uncoated mini-tablets in neonates-a randomized controlled trial. J Pediatr. 2015;167(4):893-6 e2.Google Scholar
  6. 6.
    Kluk A, Sznitowska M, Brandt A, et al. Can preschool-aged children swallow several minitablets at a time? Results from a clinical pilot study. Int J Pharm. 2015;485(1–2):1–6.PubMedCrossRefGoogle Scholar
  7. 7.
    Preis M. Orally disintegrating films and mini-tablets-innovative dosage forms of choice for pediatric use. AAPS PharmSciTech. 2015;16(2):234–41.PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Jagani M, Legay H, Ranmal SR, et al. Can a flavored spray (Pill Glide) help children swallow their medicines? A pilot study. Pediatrics. 2016;138(6):e20160680.PubMedCrossRefGoogle Scholar
  9. 9.
    Lin D, Seabrook JA, Matsui DM, et al. Palatability, adherence and prescribing patterns of antiretroviral drugs for children with human immunodeficiency virus infection in Canada. Pharmacoepidemiol Drug Saf. 2011;20(12):1246–52.PubMedCrossRefGoogle Scholar
  10. 10.
    Rieder M. How sweet it isn’t: a new formulation of sodium phenylbutyrate and the challenge of palatability for medicines for children. Arch Dis Child. 2012;97(12):1080.PubMedCrossRefGoogle Scholar
  11. 11.
    James CE, Laing DG, Oram N. A comparison of the ability of 8–9-year-old children and adults to detect taste stimuli. Physiol Behav. 1997;62(1):193–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Liem DG, de Graaf C. Sweet and sour preferences in young children and adults: role of repeated exposure. Physiol Behav. 2004;83(3):421–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Matsui D, Barron A, Rieder MJ. Assessment of the palatability of antistaphylococcal antibiotics in pediatric volunteers. Ann Pharmacother. 1996;30(6):586–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Bastiaans DET, Immohr LI, Zeinstra GG, et al. In vivo and in vitro palatability testing of a new paediatric formulation of valaciclovir. Br J Clin Pharmacol. 2017;83(12):2789–97.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Preis M, Grother L, Axe P, et al. In-vitro and in-vivo evaluation of taste-masked cetirizine hydrochloride formulated in oral lyophilisates. Int J Pharm. 2015;491(1–2):8–16.PubMedCrossRefGoogle Scholar
  16. 16.
    Bahia MS, Nissim I, Niv MY. Bitterness prediction in-silico: a step towards better drugs. Int J Pharm. 2018;536(2):526–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Vaillancourt R, Truong Y, Karmali S, et al. Instructions for masking the taste of medication for children: validation of a pictogram tool. Can Pharm J (Ott). 2017;150(1):52–9.CrossRefGoogle Scholar
  18. 18.
    Ibrahim K, Al Ansari K. Flavored intravenous ondansetron administered orally for the treatment of persistent vomiting in children. J Trop Pediatr. 2016;62(4):288–92.PubMedCrossRefGoogle Scholar
  19. 19.
    Bai S, Dormer N, Shoults C, et al. Palatability of a novel oral formulation of prednisone in healthy young adults. J Pharm Pharmacol. 2017;69(4):489–96.PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Neumann U, Whitaker MJ, Wiegand S, et al. Absorption and tolerability of taste-masked hydrocortisone granules in neonates, infants and children under 6 years of age with adrenal insufficiency. Clin Endocrinol (Oxf). 2018;88(1):21–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Goldberg SL, Giardina PJ, Chirnomas D, et al. The palatability and tolerability of deferasirox taken with different beverages or foods. Pediatr Blood Cancer. 2013;60(9):1507–12.PubMedCrossRefGoogle Scholar
  22. 22.
    Jaggupilli A, Howard R, Upadhyaya JD, et al. Bitter taste receptors: novel insights into the biochemistry and pharmacology. Int J Biochem Cell Biol. 2016;77:184–96.PubMedCrossRefGoogle Scholar
  23. 23.
    Nagtegaal MJ, Swen JJ, Hanff LM, et al. Pharmacogenetics of taste: turning bitter pills sweet? Pharmacogenomics. 2014;15(1):111–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Abdel-Rahman SM, Amidon GL, Kaul A, et al. Summary of the NICHD-BPCA pediatric formulation initiatives workshop; Pediatric Biopharmaceutics Classification System (PBCS) working group. Clin Ther. 2012;34(11):S11–24.PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Guideline on pharmaceutical development of medicines for paediatric use. London: European Medicines Agency; 2013.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  1. 1.SpringerAucklandNew Zealand

Personalised recommendations